Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Neal James R Director |
400,000 | $0 | 436,271 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Bazemore Robert B Director |
400,000 | $0 | 444,642 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
400,000 | $0 | 3,476,703 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Patel Sandip I Director |
400,000 | $0 | 912,107 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
400,000 | $0 | 3,304,728 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner |
400,000 | $0 | 5,205,311 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Hombeck Torsten CFO |
500,000 | $0 | 500,200 (Direct) |
View |
2025-03-20 Option Award |
2025-03-24 5:00 pm |
N/A 2035-03-20 |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
1,700,000 | $0 | 1,881,428 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner |
1,785,714 | $1.12 | 6,591,025 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
892,856 | $1.12 | 3,797,584 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
812,500 | $1.12 | 3,889,203 (Indirect) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Neal James R Director |
8,928 | $1.12 | 45,199 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Bazemore Robert B Director |
89,284 | $1.12 | 133,926 (Direct) |
View |
2025-03-06 Option Award |
2025-03-10 5:00 pm |
2025-03-06 2026-03-06 |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
267,856 | $1.12 | 449,284 (Direct) |
View |
2025-01-10 Option Award(A) |
2025-02-07 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
11,640 | $1.22 | 47,500 (Direct) |
View |
2025-01-10 Option Award |
2025-01-13 08:05 am |
N/A N/A |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
11,439 | $1.22 | 35,860 (Direct) |
View |
2025-01-10 Option Award |
2025-01-13 08:05 am |
N/A N/A |
Akari Therapeutics Plc | AKTX | Hombeck Torsten CFO |
200 | $1.22 | 200 (Direct) |
View |
2025-01-09 Option Award |
2025-01-10 5:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Neal James R Director |
8,000,000 | $0.0006 | 32,216,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
1,720,000 | $0.0006 | 71,720,000 (Direct) |
View |
2025-01-03 Option Award |
2025-01-07 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
208,000 | $0.0006 | 5,493,579,500 (Indirect) |
View |
2025-01-03 Option Award |
2025-01-07 4:30 pm |
2025-01-03 2035-01-03 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
152,672,000 | $0 | 5,493,579,500 (Direct) |
View |
2024-12-26 Option Award |
2024-12-30 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
3,600,000 | $0.0005 | 5,340,699,500 (Indirect) |
View |
2024-12-27 Option Award |
2024-12-30 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
40,000,000 | $0.0005 | 70,000,000 (Direct) |
View |
2024-12-26 Option Award |
2024-12-27 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Gaslightwala Abizer Director |
30,000,000 | $0.0005 | 30,000,000 (Direct) |
View |
2024-12-24 Option Award |
2024-12-27 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
7,500,000 | $0.0005 | 5,337,099,500 (Indirect) |
View |
2024-12-23 Option Award |
2024-12-26 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Neal James R Director |
2,000,000 | $0.0005 | 24,216,000 (Direct) |
View |
2024-12-23 Option Award |
2024-12-26 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
1,400,000 | $0.0005 | 5,329,599,500 (Indirect) |
View |
2024-12-20 Option Award |
2024-12-26 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
1,400,000 | $0.0005 | 5,328,199,500 (Indirect) |
View |
2024-12-02 Option Award |
2024-12-03 5:50 pm |
2024-12-02 2027-12-02 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
419,286,000 | $0.0012 | 5,908,689,500 (Indirect) |
View |
2024-11-30 Option Award |
2024-12-03 5:50 pm |
2024-11-30 2034-11-30 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
162,604,000 | $0 | 5,908,689,500 (Direct) |
View |
2024-12-02 Option Award |
2024-12-03 5:48 pm |
2024-12-02 2027-12-02 |
Akari Therapeutics Plc | AKTX | Prudo-Chlebosz Raymond Director |
419,286,000 | $0.0012 | 5,335,886,800 (Direct) |
View |
Ownership |
2024-11-22 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Sandip I Director |
0 | $0 | 1,259,014,000 (Direct) |
View |
Ownership |
2024-11-22 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Neal James R Director |
0 | $0 | 335,286,000 (Direct) |
View |
Ownership |
2024-11-22 4:30 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Huh Hoyoung Director 10% Owner |
0 | $0 | 8,632,790,000 (Direct) |
View |
2024-11-14 Option Award |
2024-11-18 8:02 pm |
N/A N/A |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
1,404,622,000 | $0 | 4,907,513,500 (Indirect) |
View |
2024-10-31 Option Award |
2024-11-01 6:00 pm |
2024-10-31 2034-10-31 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
79,684,000 | $0 | 79,684,000 (Direct) |
View |
2024-09-30 Option Award |
2024-10-02 6:34 pm |
2024-09-30 2034-09-30 |
Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director |
175,080,000 | $0 | 175,080,000 (Direct) |
View |
2024-09-17 Option Award |
2024-09-18 4:40 pm |
N/A 2034-09-17 |
Akari Therapeutics Plc | AKTX | Bazemore Robert B Director |
5,000,000 | $0 | 5,000,000 (Direct) |
View |
2024-06-28 Option Award |
2024-07-02 4:30 pm |
N/A 2034-06-28 |
Akari Therapeutics Plc | AKTX | Grissinger Michael Director |
5,000,000 | $0 | 5,000,000 (Direct) |
View |